The absolute core of our business is to best represent our significant base of corporate clients, and their relationships with existing and potential shareholders. This relationship is a function of the quality of corporate finance advice we provide to our corporate clients, the high quality of our industry research and the voice in the market that our sales and trading teams have.
Our corporate finance capabilities encompass M&A, corporate finance advisory, brokership, Sponsor and NOMADship. We represent our clients in private transactions, AIM and Main market listings.
Our research is designed to be sector focused, taking top down thematic trends, which lead us towards companies that give investors an exposure to the real growth areas of the smallcap and AIM markets.
It is the job of the sales team to keep institutions abreast of these themes and stock ideas. When there is a requirement for our corporate clients to raise money to fulfil their growth ambitions, the sales team is in a strong position to effect this, with the entrenched relationships that the team enjoys with the UK institutional and non institutional shareholder base.
Our responsibility of care to our corporate clients is augmented by our market making and trading teams, who provide liquidity in the shares of our corporate clients. We also trade the shares of non client corporates on behalf of institutions.
The recent addition of the Arden Wealth Management team offers a bespoke service to our clients, with the ability to trade/invest in equities, bonds and a range of global investment funds, as well as allowing clients to participate in Primary and Secondary equity placings.
Arden was formed in 2002 – the founding team having worked together at Albert E Sharp Securities and Old Mutual Securities.
The business was based on the pillars of quality research, market making and agency stockbroking
Following several years of impressive growth, Arden floated on AIM in 2006, with a significant amount of equity being held by the firms directors and senior employees.
In 2017 Arden raised a further tranche of equity with the objective of positioning the balance sheet ahead of the uncertainities caused to markets by the imminent introduction of MiFIDII legislation. The opportunity was also taken to ‘institutionalise’ the shareholder register.